These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 32061061)

  • 1. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
    Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
    Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of tumor characteristics on correction differences between cone-beam computed tomography-guided patient setup strategies in stereotactic body radiation therapy for lung cancer.
    Jang SS; Park SY; Cho EY; Yang PS; Huh GJ; Yang YJ
    Thorac Cancer; 2020 Feb; 11(2):311-319. PubMed ID: 31802637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The feasibility of evaluating radiation dose to the heart by integrating kilovoltage-cone beam computed tomography in stereotactic body radiotherapy of early non-small-cell lung cancer patients.
    Liu C; Gong G; Guo C; Liu T; Lu J; Zhao H; Dong W; Yin Y
    Radiat Oncol; 2013 Dec; 8():295. PubMed ID: 24369788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of SBRT response in liver cancer by combining original and delta cone-beam CT radiomics: a pilot study.
    Yang P; Shan J; Ge X; Zhou Q; Ding M; Niu T; Du J
    Phys Eng Sci Med; 2024 Mar; 47(1):295-307. PubMed ID: 38165634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients.
    Sugai Y; Kadoya N; Tanaka S; Tanabe S; Umeda M; Yamamoto T; Takeda K; Dobashi S; Ohashi H; Takeda K; Jingu K
    Radiat Oncol; 2021 Apr; 16(1):80. PubMed ID: 33931085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics-based Assessment of Radiation-induced Lung Injury After Stereotactic Body Radiotherapy.
    Moran A; Daly ME; Yip SSF; Yamamoto T
    Clin Lung Cancer; 2017 Nov; 18(6):e425-e431. PubMed ID: 28623121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A PET/CT radiomics model for predicting distant metastasis in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric study.
    Yu L; Zhang Z; Yi H; Wang J; Li J; Wang X; Bai H; Ge H; Zheng X; Ni J; Qi H; Guan Y; Xu W; Zhu Z; Xing L; Dekker A; Wee L; Traverso A; Ye Z; Yuan Z
    Radiat Oncol; 2024 Jan; 19(1):10. PubMed ID: 38254106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor volume change with stereotactic body radiotherapy (SBRT) for early-stage lung cancer: evaluating the potential for adaptive SBRT.
    Bhatt AD; El-Ghamry MN; Dunlap NE; Bhatt G; Harkenrider MM; Schuler JC; Zacarias A; Civelek AC; Pan J; Rai SN; Woo SY
    Am J Clin Oncol; 2015 Feb; 38(1):41-6. PubMed ID: 24513663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images.
    van Timmeren JE; Leijenaar RTH; van Elmpt W; Reymen B; Oberije C; Monshouwer R; Bussink J; Brink C; Hansen O; Lambin P
    Radiother Oncol; 2017 Jun; 123(3):363-369. PubMed ID: 28506693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy and inter-observer variability of 3D versus 4D cone-beam CT based image-guidance in SBRT for lung tumors.
    Sweeney RA; Seubert B; Stark S; Homann V; Müller G; Flentje M; Guckenberger M
    Radiat Oncol; 2012 Jun; 7():81. PubMed ID: 22682767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence.
    van Timmeren JE; van Elmpt W; Leijenaar RTH; Reymen B; Monshouwer R; Bussink J; Paelinck L; Bogaert E; De Wagter C; Elhaseen E; Lievens Y; Hansen O; Brink C; Lambin P
    Radiother Oncol; 2019 Jul; 136():78-85. PubMed ID: 31015133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feature selection methodology for longitudinal cone-beam CT radiomics.
    van Timmeren JE; Leijenaar RTH; van Elmpt W; Reymen B; Lambin P
    Acta Oncol; 2017 Nov; 56(11):1537-1543. PubMed ID: 28826307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of interfractional variation of the centroid position and volume of internal target volume during stereotactic body radiotherapy of lung cancer using cone-beam computed tomography.
    Sun Y; Ge H; Cheng S; Yang C; Zhu Q; Li D; Tian Y
    J Appl Clin Med Phys; 2016 Mar; 17(2):461-472. PubMed ID: 27074466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cone-beam computed tomography-based delta-radiomics for early response assessment in radiotherapy for locally advanced lung cancer.
    Shi L; Rong Y; Daly M; Dyer B; Benedict S; Qiu J; Yamamoto T
    Phys Med Biol; 2020 Jan; 65(1):015009. PubMed ID: 31307024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
    Pyka T; Bundschuh RA; Andratschke N; Mayer B; Specht HM; Papp L; Zsótér N; Essler M
    Radiat Oncol; 2015 Apr; 10():100. PubMed ID: 25900186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance.
    Sonke JJ; Rossi M; Wolthaus J; van Herk M; Damen E; Belderbos J
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):567-74. PubMed ID: 19046825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose hilar and mediastinal stereotactic body radiation therapy for non-small cell lung cancer: Analysis of outcomes in patients receiving one or multiple courses of treatment.
    Kowalchuk RO; Waters MR; Richardson M; Spencer K; Larner JM; Kersh CR
    Thorac Cancer; 2020 Jul; 11(7):2005-2013. PubMed ID: 32469465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying interfraction and intrafraction tumor motion in lung stereotactic body radiotherapy using respiration-correlated cone beam computed tomography.
    Bissonnette JP; Franks KN; Purdie TG; Moseley DJ; Sonke JJ; Jaffray DA; Dawson LA; Bezjak A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):688-95. PubMed ID: 19395200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two independent institutions.
    Bousabarah K; Blanck O; Temming S; Wilhelm ML; Hoevels M; Baus WW; Ruess D; Visser-Vandewalle V; Ruge MI; Treuer H; Kocher M
    Radiat Oncol; 2021 Apr; 16(1):74. PubMed ID: 33863358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system.
    Katoh N; Soda I; Tamamura H; Takahashi S; Uchinami Y; Ishiyama H; Ota K; Inoue T; Onimaru R; Shibuya K; Hayakawa K; Shirato H
    Radiat Oncol; 2017 Jan; 12(1):3. PubMed ID: 28057036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.